Evidence map›Paper›PMID 36845140›Full record

ArticleFrontiers in immunology2023

Anti-inflammatory effects of vagus nerve stimulation in pediatric patients with epilepsy.

Supender Kaur, Nathan R Selden, Alejandro Aballay

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Supender KaurDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, United States.
Nathan R SeldenDepartment of Neurological Surgery, Oregon Health & Science University, Portland, OR, United States.
Alejandro AballayDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, United States.
Oregon Health & Science University · USNeurological Surgery · US

Funding

Genetic analysis of innate immunity using C. elegansR01GM070977 · NIGMS · DUKE UNIVERSITY · PI ABALLAY, ALEJANDRO · 2004 to 2016
$4.2M
Genetic analysis of innate immunity using C. elegansR37GM070977 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Alejandro Aballay · 2017 to 2026
$3.8M
Mechanism of innate immune activation by intestinal distensionR01AI156900 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABALLAY, ALEJANDRO · 2020 to 2024
$2.0M
NIAID NIH HHS R01 AI156900NIGMS NIH HHS R01 GM070977NIGMS NIH HHS R37 GM070977
6 · The paper itself

Abstract

Introduction: The neural control of the immune system by the nervous system is critical to maintaining immune homeostasis, whose disruption may be an underlying cause of several diseases, including cancer, multiple sclerosis, rheumatoid arthritis, and Alzheimer's disease. Methods: Here we studied the role of vagus nerve stimulation (VNS) on gene expression in peripheral blood mononuclear cells (PBMCs). Vagus nerve stimulation is widely used as an alternative treatment for drug-resistant epilepsy. Thus, we studied the impact that VNS treatment has on PBMCs isolated from a cohort of existing patients with medically refractory epilepsy. A comparison of genome-wide changes in gene expression was made between the epilepsy patients treated and non-treated with vagus nerve stimulation. Results: The analysis showed downregulation of genes related to stress, inflammatory response, and immunity, suggesting an anti-inflammatory effect of VNS in epilepsy patients. VNS also resulted in the downregulation of the insulin catabolic process, which may reduce circulating blood glucose. Discussion: These results provide a potential molecular explanation for the beneficial role of the ketogenic diet, which also controls blood glucose, in treating refractory epilepsy. The findings indicate that direct VNS might be a useful therapeutic alternative to treat chronic inflammatory conditions.

Indexed as

Drug Resistant EpilepsyEpilepsyVagus Nerve StimulationAnti-Inflammatory AgentsBlood GlucoseChildHumansLeukocytes, MononuclearAnti-Inflammatory AgentsBlood Glucoseblood glucosecytokinesinsulinneuroimmuneperipheral blood monocytes cellsseizuretumor necrosis factorvagus nerve stimulation

Identifiers

PMID36845140
PMCPMC9951815
OpenAlexW4319986238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.